Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape.

Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood. Symptoms include drowsiness, shortness of breath, fatigue, seizures or coma in severe cases and chest pain. The predisposing factors include age, diabetes, high blood pressure, heart failure and kidney diseases. Treatment includes antibiotics and diuretics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Acut...

Summary

GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain compet...

Summary

GlobalData's clinical trial report, “Renal Insufficiency Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Renal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Insufficiency . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strate...

Summary

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Renal Anemia market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher -
- Executive Summary: Contains analysis of key market events that have occurred during the previous month and which have impacted Sociable Pharma’s view of the disease landscape
- Landscape Updates: ‘Order of Entry’ analysis, detailing timeline forecasts for each drug in Phase II development or higher; Timeline forecasts for each approved product’s lifecycle management initiatives; ‘Market Entry’ & ‘Direction of Travel’ positioning analysis for pipeline & currently approved therapies
- Pipeline Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019
- Approved Product Landscape: An overview of pipeline candidates, containing snapshots of current develop...

Summary

GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2018" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the deci...

Summary

GlobalData's clinical trial report, “Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2018" provides an overview of Uremic (Renal) Pruritus clinical trials scenario. This report provides top line data relating to the clinical trials on Uremic (Renal) Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strate...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (cancerous) and grows out of control, forming a tumor. Symptoms include blood in urine, loss of appetite, fever that lasts for weeks, extreme fatigue, and anemia, shortness of breath and bone pain. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Kidney Cancer (Renal Cell Cancer) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive...

Summary

GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the deci...

Summary

With the growth of the elderly population and patients with diabetes and hypertension, the prevalence of kidney disease is increasing, which leads the rising demand for renal dialysis equipment. Hemodialysis products dominate over 70% of the renal dialysis equipment market, due to high familiarity with the hemodialysis procedure among healthcare providers, the large number of hemodialysis centers, and favorable reimbursement. However, because of the convenience of home-based procedures, technological innovation, and the relatively low cost, peritoneal dialysis has consistently gained acceptance. As a result, the peritoneal dialysis products market is growing robustly. In addition, with the rising adoption of continuous renal replacement therapy, the market for continuous renal replacement therapy machines expands rapidly. This report examines the renal dialysis equipment market in five major European markets: France, Germany, Italy, Spain, and the UK.

This report provides insight into the adoption trends, market dynamics, competitive landscape, markete...

Summary

Renal dialysis equipment is categorized into the following segments: hemodialysis products, peritoneal dialysis products, and continuous renal replacement therapy machines.

Hemodialysis products dominate over 70% of the market, whereas the peritoneal dialysis products market is growing robustly. The market for continuous renal replacement therapy machines has the highest growth rate.

Growth in the renal dialysis equipment market will be driven primarily by aging populations, growing awareness of therapeutic modalities, technological innovation and favorable reimbursement.

Home-based dialysis, including peritoneal dialysis and home hemodialysis, improves the quality of patients’ life and will become more popular.

The global market is dominated by Fresenius and Baxter.

Other key players include B. Braun, Nikkiso, Nipro, and NxStage.

Highlights

Key Questions Answered

- What is the current and future renal dialysis equipment market outlook in the developed and emerging markets? What trends and events are a...

Summary

With the growth of the elderly population and patients with diabetes and hypertension, the prevalence of kidney disease is increasing, which leads the rising demand for renal dialysis equipment. Hemodialysis products dominate over 70% of the renal dialysis equipment market, due to high familiarity with the hemodialysis procedure among healthcare providers, the large number of hemodialysis centers, and favorable reimbursement. However, because of the convenience of home-based procedures, technological innovation, and the relatively low cost, peritoneal dialysis has consistently gained acceptance. As a result, the peritoneal dialysis products market is growing robustly. In addition, with the rising adoption of continuous renal replacement therapy, the market for continuous renal replacement therapy machines expands rapidly.

The report provides up-to-date information and in-depth analysis on the key players that shape the global renal dialysis equipment market. The report also includes analysis of company profiles, industry trends, and corporate strategy....

Summary

With the growth of the elderly population and patients with diabetes and hypertension, the prevalence of kidney disease is increasing, which leads the rising demand for renal dialysis equipment. Hemodialysis products dominate over 70% of the renal dialysis equipment market, due to high familiarity with the hemodialysis procedure among healthcare providers, the large number of hemodialysis centers, and favorable reimbursement. However, because of the convenience of home-based procedures, technological innovation, and the relatively low cost, peritoneal dialysis has consistently gained acceptance. As a result, the peritoneal dialysis products market is growing robustly. In addition, with the rising adoption of continuous renal replacement therapy, the market for continuous renal replacement therapy machines expands rapidly. This report examines the renal dialysis equipment market in the major North American markets, the US.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, curre...

Summary

With the growth of the elderly population and patients with diabetes and hypertension, the prevalence of kidney disease is increasing, which leads the rising demand for renal dialysis equipment. Hemodialysis products dominate over 70% of the renal dialysis equipment market, due to high familiarity with the hemodialysis procedure among healthcare providers, the large number of hemodialysis centers, and favorable reimbursement. However, because of the convenience of home-based procedures, technological innovation, and the relatively low cost, peritoneal dialysis has consistently gained acceptance. As a result, the peritoneal dialysis products market is growing robustly. In addition, with the rising adoption of continuous renal replacement therapy, the market for continuous renal replacement therapy machines expands rapidly. This report examines the renal dialysis equipment market in three major APAC markets: China, India, and Japan.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline produc...

Summary

With the growth of the elderly population and patients with diabetes and hypertension, the prevalence of kidney disease is increasing, which leads the rising demand for renal dialysis equipment. Hemodialysis products dominate over 70% of the renal dialysis equipment market, due to high familiarity with the hemodialysis procedure among healthcare providers, the large number of hemodialysis centers, and favorable reimbursement. However, because of the convenience of home-based procedures, technological innovation, and the relatively low cost, peritoneal dialysis has consistently gained acceptance. As a result, the peritoneal dialysis products market is growing robustly. In addition, with the rising adoption of continuous renal replacement therapy, the market for continuous renal replacement therapy machines expands rapidly. This report examines the renal dialysis equipment market in the major South American market, Brazil.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, curren...

Summary

Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Metastatic Renal Cell Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Metastatic Renal Cell Carcinoma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, c...

Summary

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2016’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets ...

Summary

GlobalData's clinical trial report, “Renal Artery Stenosis Global Clinical Trials Review, H2, 2016" provides an overview of Renal Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies t...

Summary

Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. RCC is the most common type of kidney cancer in adults, being responsible for approximately 90% of all cases in adults. The condition is asymptomatic in its initial stages, and as a result, people with RCC are often in the advanced stages of the disease by the time it is discovered. The initial symptoms of RCC often include blood in the urine, flank pain, a mass in the abdomen or flank, weight loss, fever, hypertension, night sweats, and a general feeling of being unwell. Kidney cancer is among the 10 most frequently occurring cancers in Western countries. Globally, about 270,000 cases of kidney cancer are diagnosed yearly, and 116,000 people die from the disease.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of RCC in the 8MM, from 190,147 diagnosed incident cases in 2013 to 309,734 diagnosed incid...

Summary

GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the deci...

Summary

Global Markets Direct’s, ‘Renal Insufficiency - Pipeline Review, H1 2016’, provides an overview of the Renal Insufficiency pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Renal Insufficiency, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Renal Insufficiency and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filin...

Summary

Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Metastatic Renal Cell Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Metastatic Renal Cell Carcinoma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, c...